About BioSig Technologies, Inc.
BioSig Technologies, Inc. operates as a medical device company. It engages in the development of proprietary biomedical signal processing technology platform to minimize noise and artifacts from cardiac recordings. The company develops and designs the precise uninterrupted real-time evaluation of electrograms electrophysiology (EP) system which acquires, processes, and displays electrocardiogram and electrograms required during EP studies and ablation procedures. BioSig Technologies was founded by Lora Mikolaitis, Budimir S. Drakulic and Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.